Shufang Liao
15 Lequn Road
Guilin, 541001, China
Guilin, 541001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Adjuvant apatinib therapy following concurrent chemoradiotherapy in patients with high-risk nasopharyngeal carcinoma: A multicenter, prospective phase 2 study.
Journal: Translational oncology
Published: March 19, 2026
Comparing three induction regimens for nasopharyngeal carcinoma: a propensity score-matched analysis.
Journal: Therapeutic advances in medical oncology
Published: September 10, 2025
SARS-CoV-2 infection and its effects on toxicity and survival in non-metastatic nasopharyngeal carcinoma: a matched cohort study.
Journal: BMC cancer
Published: August 23, 2025
An individualized immune prognostic signature in nasopharyngeal carcinoma.
Journal: Oral oncology
Published: May 12, 2024
Intensity-modulated radiotherapy alone compared with intensity-modulated radiotherapy plus concurrent chemotherapy in intermediate-risk nasopharyngeal carcinoma : A prospective multicenter phase II trial.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: June 14, 2023
Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma.
Journal: Radiation oncology (London, England)
Published: November 05, 2019
Superiority of intensity-modulated radiation therapy in nasopharyngeal carcinoma with skull-base invasion.
Journal: Journal of cancer research and clinical oncology
Published: June 03, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026